Gene · 10666
Papers4,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alterations in peripheral blood NK cell subsets and function in patients with HBeAg-positive chronic hepatitis B during pregnancy. | Front Cell Infect Microbiol | 2025 | 41122687 | PubTator, text mining | PubMed |
| Phenotypes, mechanisms, and therapeutic strategies of natural killer cell immunosenescence. | Immun Ageing | 2025 | 41121385 | PubTator, text mining | PubMed |
| Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killing. | Cell Death Dis | 2025 | 41102150 | PubTator, text mining | PubMed |
| Enhancing anti-tumor immunity through TIGIT blockade and tumor-directed targeting in pancreatic cancer. | Int Immunopharmacol | 2025 | 41101232 | PubTator, text mining | PubMed |
| The Development of Monoclonal Antibodies Specific to the Soluble Form of CD155 in the Human Peripheral Blood. | Monoclon Antib Immunodiagn Immunother | 2025 | 41090489 | PubTator, text mining | PubMed |
| Editorial: Exploring lymphocyte signaling: from health to disease. | Front Immunol | 2025 | 41070361 | PubTator, text mining | PubMed |
| CD8+ T-NK cell crosstalk establishes preemptive immunosurveillance to eliminate antigen-escape tumors. | Front Immunol | 2025 | 41058706 | PubTator, text mining | PubMed |
| Phenotypic and epigenetic profiles of circulating NK cells in spontaneous HIV-1 controllers. | EBioMedicine | 2025 | 41027310 | PubTator, text mining | PubMed |
| Tumor-priming CD8+ natural killer T-like cells as an efficient novel cell therapy for relapsed/refractory multiple myeloma. | Exp Hematol Oncol | 2025 | 41024291 | PubTator, text mining | PubMed |
| ZNF180 modulates tumor intrinsic immunotherapy resistance in melanoma through driving plasticity. | bioRxiv | 2025 | 41000822 | PubTator, text mining | PubMed |
| IL-21-reprogrammed Vδ1 T cells exert killing against solid tumors which is enhanced by CAR arming for off-the-shelf immunotherapy. | Oncoimmunology | 2025 | 40996786 | PubTator, text mining | PubMed |
| Second signals for cancer immunotherapy. | J Immunother Cancer | 2025 | 40992782 | PubTator, text mining | PubMed |
| Expression of Co-Inhibitory Molecules on Lymphocytes of Patients With Psoriasis. | J Dermatol | 2025 | 40988543 | PubTator, text mining | PubMed |
| The cGAS-STING pathway is a master regulator of OCT4 expression in persistent sarcoma cells and enhances cellular immunotherapy with NK and CIK lymphocytes. | Cancer Immunol Immunother | 2025 | 40986050 | PubTator, text mining | PubMed |
| Analysis of vitamin D-induced immunomodulatory gene expression changes in type 1 diabetes: from computational prediction to experimental validation. | Mol Biol Rep | 2025 | 40982162 | PubTator, text mining | PubMed |
| Advancing our understanding of the influence of myeloid-derived suppressor cells in chronic myeloid leukemia. | J Cancer Res Clin Oncol | 2025 | 40970984 | PubTator, text mining | PubMed |
| Single-Cell Multi-Omics Deciphers Core Gene Networks and Immune Interaction Collapse in Sepsis-Associated T Cell Dysfunction. | Infect Drug Resist | 2025 | 40969714 | PubTator, text mining | PubMed |
| Monocyte/macrophage-derived interleukin-15 mediates the pro-inflammatory phenotype of CD226+ B cells in type 1 diabetes. | EBioMedicine | 2025 | 40957221 | PubTator, text mining | PubMed |
| Tumour Single-Cell Bioinformatics: From Immune Profiling to Molecular Dynamics. | J Cell Mol Med | 2025 | 40954554 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model based on mitochondria-associated endoplasmic reticulum membranes gene signature in LUAD patients. | PLoS One | 2025 | 40953006 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10666/papers?page=7